ABIN1383733
antibody from antibodies-online
Targeting: TNFRSF10A
Apo2, CD261, DR4, TRAILR-1, TRAILR1
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1383733 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A) antibody
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Ion exchange chromatography
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- B-N28
- Vial size
- 200μl
- Concentration
- 200μg/200μl
- Storage
- Declared stable after 7 days at room temperature. Protect from light. Do not freeze.
Submitted references The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.
CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.
CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Characterization of monoclonal antibodies directed against trail or trail receptors.
Raja SM, Chen S, Yue P, Acker TM, Lefkove B, Arbiser JL, Khuri FR, Sun SY
Molecular cancer therapeutics 2008 Jul;7(7):2212-23
Molecular cancer therapeutics 2008 Jul;7(7):2212-23
CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.
Lin YD, Chen S, Yue P, Zou W, Benbrook DM, Liu S, Le TC, Berlin KD, Khuri FR, Sun SY
Cancer research 2008 Jul 1;68(13):5335-44
Cancer research 2008 Jul 1;68(13):5335-44
CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Chen S, Liu X, Yue P, Schönthal AH, Khuri FR, Sun SY
Molecular pharmacology 2007 Nov;72(5):1269-79
Molecular pharmacology 2007 Nov;72(5):1269-79
Characterization of monoclonal antibodies directed against trail or trail receptors.
Vermot-Desroches C, Sergent E, Bonnin B, Wijdenes J
Cellular immunology 2005 Jul-Aug;236(1-2):86-91
Cellular immunology 2005 Jul-Aug;236(1-2):86-91
No comments: Submit comment
No validations: Submit validation data